Clayens Group, an outsourced contract manufacturer of polymers, composites and metals headquartered in France and a portfolio company of One Equity Partners, has purchased plastics manufacturer Parkway Products LLC and has completed a carve-out of the Crystal Lake, Ill. injection molding manufacturing facility and transfer of in-house operations from a global healthcare corporation.

Founded in 1946 and headquartered in Greenville, S.C., Parkway manufactures plastic parts and offers plastics and molding processing services including thermoplastics, thermoset and machined plastics, as well as magnesium thixomolding and polymers molding. From its eight facilities in the U.S. and one in Mexico, Parkway serves clients in the industrial, infrastructure, agriculture, aerospace and defense, transportation and healthcare markets. Clayen’s Crystal Lake manufacturing business includes a 473,000-square-foot facility with clean room operations and is primarily involved in the production of plastic-based products for the medical sector, such as medical waste containers and syringes.

“The acquisition of Parkway Products creates synergies that enable first-class production of high-performance polymers, composites and precision metals that enhances both companies’ technical expertise and overall client reach,” says Clayens’ CEO Eric Pisani. “The purchase of the Crystal Lake facility helps achieve our strategic goal of boosting our healthcare capabilities by expanding manufacturing capacity in the U.S.”